ATYR logo

ATyr Pharma (ATYR) EBITDA

Annual EBITDA

-$52.18 M
-$7.47 M-16.71%

December 31, 2023

Summary

Performance

1-Year Change

-16.71%

3-Year Change

-256.29%

5-Year Change

-62.68%

15-Year Change

-12.38%

ATYR EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

31.46%
ATYR annual EBITDA is higher than 31.46% of companies in Healthcare sector

High & Low

All-time High

-$14.64 M

3-Year Low

-$52.18 M
ATYR annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ATYR previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 14, 2025
ATYR next annual earnings announcement is scheduled for Mar 14, 2025

OtherATYRprofitabilitymetrics:

Annual Revenue

$353.00 K
ATYR annual revenue is $353.00 thousand

Annual Net Income

-$50.39 M
ATYR annual net profit is -$50.39 million

Annual EBIT

-$54.92 M
ATYR annual earnings before interest & taxes is -$54.92 million

Annual EPS

-$0.94
ATYR annual earnings per share is -$0.94

Quarterly EBITDA

-$17.75 M
-$823.00 K-4.86%

September 1, 2024

Summary

Performance

3-Month Change

-4.86%

1-Year Change

-4.86%

3-Year Change

-144.8%

5-Year Change

-144.8%

ATYR Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

25.34%
ATYR quarterly EBITDA is higher than 25.34% of companies in Healthcare sector

High & Low

All-time High

$2.22 M
ATYR quarterly EBITDA is currently -900.86% below its historical high of $2.22 million

3-Year Low

-$17.75 M
ATYR quarterly EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
ATYR previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 14, 2025
ATYR next earnings announcement is scheduled for Mar 14, 2025

OtherATYRprofitabilitymetrics:

Quarterly Revenue

-
ATYR quarterly revenue value is unknown

Quarterly Net Income

-$17.26 M
ATYR quarterly net profit is -$17.26 million

Quarterly EBIT

-$18.14 M
ATYR quarterly earnings before interest & taxes is -$18.14 million

Quarterly EPS

-$0.23
ATYR quarterly earnings per share is -$0.23

TTM EBITDA

-$66.11 M
-$6.13 M-10.23%

September 1, 2024

Summary

Performance

3-Month Change

-10.23%

1-Year Change

-10.23%

3-Year Change

-47.86%

5-Year Change

-47.86%

ATYR TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

26.19%
ATYR TTM EBITDA is higher than 26.19% of companies in Healthcare sector

High & Low

All-time High

-$5.73 M

3-Year Low

-$66.11 M
ATYR TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
ATYR previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 14, 2025
ATYR next earnings announcement is scheduled for Mar 14, 2025

OtherATYRprofitabilitymetrics:

TTM Revenue

-
ATYR TTM revenue value is unknown

TTM Net Income

-$63.82 M
ATYR TTM net profit is -$63.82 million

TTM EBIT

-$68.05 M
ATYR TTM earnings before interest & taxes is -$68.05 million

TTM EPS

-$0.94
ATYR TTM earnings per share is -$0.94

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$52.18 M
ATYR annual EBITDA is -$52.18 million

Annual Net Income

-$50.39 M
ATYR annual net profit is -$50.39 million

Annual Interest Expense

-
ATYR annual interest expense value is unknown

Annual Income Tax

-
ATYR annual income tax value is unknown

Annual D&A

$2.74 M
ATYR annual depreciation & amortization is $2.74 million

ATYR EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-16.7%-4.9%-10.2%
3 y3 years-256.3%-144.8%-47.9%
5 y5 years-62.7%-144.8%-47.9%

ATYR EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-59.5%at low-144.8%at low-102.1%at low
5 y5-year-256.3%at low-900.9%at low-377.1%at low
alltimeall time-256.3%+8.5%-900.9%at low-1054.3%at low

ATyr Pharma EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$17.75 M(+4.9%)
-$66.11 M(+10.2%)
Jun 2024
-
-$16.93 M(+6.7%)
-$59.97 M(+7.1%)
Mar 2024
-
-$15.87 M(+2.0%)
-$56.01 M(+7.3%)
Dec 2023
-$52.18 M(+16.7%)
-$15.55 M(+33.8%)
-$52.18 M(+18.9%)
Sep 2023
-
-$11.62 M(-10.4%)
-$43.88 M(-3.2%)
Jun 2023
-
-$12.97 M(+7.8%)
-$45.34 M(+1.5%)
Mar 2023
-
-$12.03 M(+65.9%)
-$44.66 M(-0.1%)
Dec 2022
-$44.71 M(+36.7%)
-
-
Dec 2022
-
-$7.25 M(-44.5%)
-$44.71 M(-2.3%)
Sep 2022
-
-$13.08 M(+6.3%)
-$45.78 M(+14.2%)
Jun 2022
-
-$12.30 M(+1.8%)
-$40.10 M(+5.8%)
Mar 2022
-
-$12.08 M(+45.2%)
-$37.89 M(+15.8%)
Dec 2021
-$32.71 M(+123.4%)
-$8.32 M(+12.4%)
-$32.71 M(+12.5%)
Sep 2021
-
-$7.40 M(-26.6%)
-$29.09 M(+4.3%)
Jun 2021
-
-$10.09 M(+46.1%)
-$27.90 M(+17.4%)
Mar 2021
-
-$6.91 M(+47.1%)
-$23.77 M(+62.3%)
Dec 2020
-$14.64 M(-32.2%)
-$4.69 M(-24.4%)
-$14.64 M(-5.9%)
Sep 2020
-
-$6.21 M(+4.3%)
-$15.56 M(+7.3%)
Jun 2020
-
-$5.96 M(-368.7%)
-$14.51 M(+4.7%)
Mar 2020
-
$2.22 M(-139.5%)
-$13.85 M(-35.9%)
Dec 2019
-$21.61 M
-$5.61 M(+8.8%)
-$21.61 M(-0.8%)
Sep 2019
-
-$5.16 M(-2.8%)
-$21.79 M(-5.7%)
DateAnnualQuarterlyTTM
Jun 2019
-
-$5.30 M(-4.3%)
-$23.11 M(-16.2%)
Mar 2019
-
-$5.54 M(-4.2%)
-$27.58 M(-14.0%)
Dec 2018
-$32.07 M(-30.9%)
-$5.78 M(-10.8%)
-$32.07 M(-14.1%)
Sep 2018
-
-$6.49 M(-33.6%)
-$37.33 M(-10.1%)
Jun 2018
-
-$9.77 M(-2.7%)
-$41.52 M(-4.5%)
Mar 2018
-
-$10.04 M(-9.1%)
-$43.48 M(-6.4%)
Dec 2017
-$46.43 M(-18.6%)
-$11.04 M(+3.4%)
-$46.43 M(-2.7%)
Sep 2017
-
-$10.68 M(-9.0%)
-$47.70 M(-5.9%)
Jun 2017
-
-$11.73 M(-9.6%)
-$50.67 M(-6.4%)
Mar 2017
-
-$12.98 M(+5.5%)
-$54.14 M(-5.1%)
Dec 2016
-$57.04 M(+22.0%)
-$12.31 M(-9.8%)
-$57.04 M(-6.5%)
Sep 2016
-
-$13.64 M(-10.3%)
-$60.99 M(+4.4%)
Jun 2016
-
-$15.21 M(-4.2%)
-$58.44 M(+8.4%)
Mar 2016
-
-$15.88 M(-2.3%)
-$53.92 M(+15.3%)
Dec 2015
-$46.75 M(+105.7%)
-$16.26 M(+46.6%)
-$46.75 M(+28.7%)
Sep 2015
-
-$11.09 M(+3.8%)
-$36.31 M(+16.2%)
Jun 2015
-
-$10.69 M(+22.7%)
-$31.24 M(+21.5%)
Mar 2015
-
-$8.71 M(+49.7%)
-$25.71 M(+13.1%)
Dec 2014
-$22.73 M(+20.7%)
-$5.82 M(-3.3%)
-$22.73 M(+34.4%)
Sep 2014
-
-$6.02 M(+16.8%)
-$16.90 M(+55.3%)
Jun 2014
-
-$5.16 M(-10.0%)
-$10.88 M(+90.0%)
Mar 2014
-
-$5.73 M
-$5.73 M
Dec 2013
-$18.83 M
-
-

FAQ

  • What is aTyr Pharma annual EBITDA?
  • What is the all time high annual EBITDA for aTyr Pharma?
  • What is aTyr Pharma annual EBITDA year-on-year change?
  • What is aTyr Pharma quarterly EBITDA?
  • What is the all time high quarterly EBITDA for aTyr Pharma?
  • What is aTyr Pharma quarterly EBITDA year-on-year change?
  • What is aTyr Pharma TTM EBITDA?
  • What is the all time high TTM EBITDA for aTyr Pharma?
  • What is aTyr Pharma TTM EBITDA year-on-year change?

What is aTyr Pharma annual EBITDA?

The current annual EBITDA of ATYR is -$52.18 M

What is the all time high annual EBITDA for aTyr Pharma?

aTyr Pharma all-time high annual EBITDA is -$14.64 M

What is aTyr Pharma annual EBITDA year-on-year change?

Over the past year, ATYR annual EBITDA has changed by -$7.47 M (-16.71%)

What is aTyr Pharma quarterly EBITDA?

The current quarterly EBITDA of ATYR is -$17.75 M

What is the all time high quarterly EBITDA for aTyr Pharma?

aTyr Pharma all-time high quarterly EBITDA is $2.22 M

What is aTyr Pharma quarterly EBITDA year-on-year change?

Over the past year, ATYR quarterly EBITDA has changed by -$823.00 K (-4.86%)

What is aTyr Pharma TTM EBITDA?

The current TTM EBITDA of ATYR is -$66.11 M

What is the all time high TTM EBITDA for aTyr Pharma?

aTyr Pharma all-time high TTM EBITDA is -$5.73 M

What is aTyr Pharma TTM EBITDA year-on-year change?

Over the past year, ATYR TTM EBITDA has changed by -$6.13 M (-10.23%)